<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is an acquired thrombophilic disorder characterized by the presence of autoantibodies to a variety of <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding proteins </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical manifestations range from being asymptomatic to having imminently life-threatening events </plain></SENT>
<SENT sid="2" pm="."><plain>Catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (CAPS) occurs in &lt;1% of patients with APS and is defined by multiple small-vessel occlusions that lead to multiple-organ failure and is associated with high morbidity and mortality rates </plain></SENT>
<SENT sid="3" pm="."><plain>Here we report the case of a 3-month-old boy with probable CAPS who presented to us with digital <z:mp ids='MP_0001651'>necrosis</z:mp> and <z:mp ids='MP_0001182'>pulmonary hemorrhage</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, a skin biopsy demonstrated multiple small-vessel thromboses without signs of <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Results of testing for autoantibodies were positive for anti-beta(2) <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-beta(2)-GPI) only </plain></SENT>
<SENT sid="6" pm="."><plain>His treatment consisted of high-dose steroids, immunoglobulin therapy, exchange transfusion, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, and rituximab as well as iloprost and <z:chebi fb="0" ids="51450">bosentan</z:chebi> as <z:chebi fb="1" ids="35620">vasodilators</z:chebi> for his <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>; he showed an excellent clinical response </plain></SENT>
<SENT sid="7" pm="."><plain>To the best of our knowledge, this is the youngest patient with probable CAPS, the first reported patient to test positive for anti-beta(2)-GPI antibodies and negative for anticardiolipin antibodies and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, and the second patient reported to be successfully treated with an immunomodulatory regimen including rituximab </plain></SENT>
</text></document>